Screener
PCRB vs PVAL
Putnam ESG Core Bond ETF - vs Putnam Focused Large Cap Value ETF
Key differences
- PCRB costs 0.19% less per year.
- PVAL is significantly larger than PCRB — larger funds tend to be more liquid and less likely to close.
- PCRB is classified as fixed income, while PVAL is equity — different risk/return profiles.
- PCRB follows a index tracking strategy; PVAL uses active selection.
- Over the last 3 years, PVAL has delivered higher annualized returns.
Side-by-side comparison
| PCRB | PVAL | |
|---|---|---|
| Annual cost (TER) | 0.36% | 0.55% |
| Fund size (AUM) | $7M | $10.1B |
| Since | 2023 | 2021 |
| Dividend yield | 9.54% | 1.00% |
| Asset class | fixed income | equity |
| Region | north america | north america |
| Strategy | index tracking | active selection |
| CAGR 1Y | +5.3% | +33.6% |
| CAGR 3Y | +3.9% | +24.1% |
| CAGR 5Y | N/A | N/A |
| Sharpe 3Y | 0.08 | 1.41 |
| Volatility 1Y | 3.79% | 10.94% |
| Max drawdown | -7.20% | -16.64% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PCRB and PVAL
Explore further